Clifford Berkman

Oncology
Cancer Targeted Technology
United States of America

Biography

Dr. Cliff Berkman, CSO, Founder and Director of CTT and Professor of Chemistry at Washington State University. He has over 25 years of experience in developing novel enzyme inhibitors for use in detecting tumors and sensitizing tumor cells to chemotherapeutics and targeted radionuclides. CTT’s technology and lead drugs were designed and developed by Dr. Berkman.

Research Interest

Oncology

Global Experts from United States of America

Global Experts in Subject

Share This Profile

Recent Expert Updates

Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone Matthew
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. Matthew L Stone
pediatrics
University of Virginia Health System; Charlottesville, VA
United States of America
Dr. R Sameh
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. Sameh R Ismail,
pediatrics
King Abdul Aziz University
United Arab Emirates
Dr. William
pediatrics
Maimonides Medical Center
United States of America